Skip to content

Technology

Behind On COVID, This Immunology Stock’s Real Value Could Come From Another Product In Its Pipeline

Despite its focus on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases, the clinical-stage company featured in today’s article is woefully behind the likes of Pfizer, Moderna, Johnson & Johnson and AstraZeneca when it comes to its COVID-19 product – its lead product. But the real value for this company may come from another product… 

CLICK HERE »Behind On COVID, This Immunology Stock’s Real Value Could Come From Another Product In Its Pipeline

Making Some Green From A Graying Population

Sure, you know that people around the world are living longer, but do you know how to make money off this “global aging megatrend”? Today’s article highlights a recent report on this unprecedented demographic shift and its investment implications. What potentially lucrative investment opportunities exist in the areas of real estate and health care & technology, and how can you… 

CLICK HERE »Making Some Green From A Graying Population